Abstract
therapy of cutaneous T-cell lymphoma: the Yale-New Haven Hospital experience. Yale J Biol Med 1989;62:62938. 5. Heald PW. Photopheresis for cutaneous T cell lymphoma. Ann N Y Acad Sci 1991;636:171-7. 6. Heald P, Yan S-L, Edelson R. Profound deficiency in normal circulating T cells in erythrodermic cutaneous T-cell lymphoma. Arch Dermatol 1994; 130: 198-203. 7. Edelson R, Berger C, Gasparro F, et al. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy: preliminary results. N Engl J Med 1987;3 16:297303. 8. Haynes BF, Metzgar RS, Minna JD, et al. Phenotypic characterization of cuaneous T-cell lymphoma: use of monoclonal antibodies to compare with other malignant T cells. N Engl J Med 1981;304:1319-23. 9. Weinberg JM, Rook AH, Lessin SR. Molecular diagnosis of lymphocytic infiltrates of the skin. Arch Dermatoll993; 129:1491-500. 10. Davis AL, McKenzie JL, Hart DNJ. HLA-DR-positive leucocyte subpopulations in human skin include dendritic cells, macrophages, and CD7-negative T cells. Immunology 1988;65:573-81. 11. Labastide WB, Rana MT, Barker CR. A new monoclonal antibody (CH-F42) recognizes a CD7-subset of normal T lymphocytes and circulating malignant cells in adult T-cell lymphoma-leukemia and Sezary syndrome. Blood 1990; 76:1361-S. 12. Kuzel TM, Roenigk HH, Rosen ST. Mycosis fungoides and the Sezary syndrome: a review of pathogenesis, diagnosis, and therapy. J Clin Oncol 1991;9:1298-313.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
